Our group is supported by the European Regional Development Fund through the Regional Operational Program Center 2020, Competitiveness Factors Operational Program (COMPETE 2020) and National Funds through Foundation for Science and Technology (FCT): BrainHealth2020 projects (CENTRO-01-0145-FEDER-000008), ViraVector (CENTRO-01-0145-FEDER- 022095), CortaCAGs (POCI-01-0145-FEDER-016719), SpreadSilencing POCI-01- 0145-FEDER-029716, Imagene POCI-01-0145-FEDER-016807, CancelStem POCI-01-0145-FEDER-016390, as well as UID4950/2020 (to MCB), BIN – National Brain Imaging Network (CENTRO-01-0145-FEDER-022118) and the Association Française contre les Myopathies -Téléthon no. 21163 and the SynSpread, European SCA3/MJD Initiative and ModelPolyQ under the EU Joint Program, the last two co-funded by the European Union H2020 program, GA No. 643417; by National Ataxia Foundation, the American Portuguese Biomedical Research Fund and the Richard Chin and Lily Lock Machado-Joseph Disease Research Fund.


Project title
Our group is supported by the European Regional Development Fund through the Regional Operational Program Center 2020, Competitiveness Factors Operational Program (COMPETE 2020) and National Funds through Foundation for Science and Technology (FCT): BrainHealth2020 projects (CENTRO-01-0145-FEDER-000008), ViraVector (CENTRO-01-0145-FEDER- 022095), CortaCAGs (POCI-01-0145-FEDER-016719), SpreadSilencing POCI-01- 0145-FEDER-029716, Imagene POCI-01-0145-FEDER-016807, CancelStem POCI-01-0145-FEDER-016390, as well as UID4950/2020 (to MCB), BIN – National Brain Imaging Network (CENTRO-01-0145-FEDER-022118) and the Association Française contre les Myopathies -Téléthon no. 21163 and the SynSpread, European SCA3/MJD Initiative and ModelPolyQ under the EU Joint Program, the last two co-funded by the European Union H2020 program, GA No. 643417; by National Ataxia Foundation, the American Portuguese Biomedical Research Fund and the Richard Chin and Lily Lock Machado-Joseph Disease Research Fund.